These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy. Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534 [TBL] [Abstract][Full Text] [Related]
45. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children. Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Boyce W; Jose L; Koen A; Moultrie A; Cutland CL; Grobbee DE; Klipstein-Grobusch K; Madhi SA J Infect Dis; 2019 Sep; 220(9):1529-1538. PubMed ID: 31282539 [TBL] [Abstract][Full Text] [Related]
46. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture. Taniuchi M; Begum S; Uddin MJ; Platts-Mills JA; Liu J; Kirkpatrick BD; Chowdhury AH; Jamil KM; Haque R; Petri WA; Houpt ER J Clin Microbiol; 2015 Jan; 53(1):206-11. PubMed ID: 25378579 [TBL] [Abstract][Full Text] [Related]
47. Specific antibodies to poliovirus type I in breastmilk of unvaccinated mothers before and seven years after start of community-wide vaccination of their infants with live, oral poliovirus vaccine. Zaman S; Carlsson B; Jalil F; Jeansson S; Mellander L; Hanson LA Acta Paediatr Scand; 1991 Dec; 80(12):1174-82. PubMed ID: 1785290 [TBL] [Abstract][Full Text] [Related]
48. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants. Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357 [TBL] [Abstract][Full Text] [Related]
49. [Study on safety and immunogenicity of oral poliomyelitis attenuated live vaccine (human diploid cell)]. Guo SH; Tao H; Ying ZF Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):193-6. PubMed ID: 20726255 [TBL] [Abstract][Full Text] [Related]
50. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. Maldonado YA; Peña-Cruz V; de la Luz Sanchez M; Logan L; Blandón S; Cantwell MF; Matsui SM; Millan-Velasco F; Valdespino JL; Sepulveda J J Infect Dis; 1997 Mar; 175(3):545-53. PubMed ID: 9041324 [TBL] [Abstract][Full Text] [Related]
51. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials. John TJ; Jain H; Ravishankar K; Amaresh A; Verma H; Deshpande J; Pallansch MA; Singh AP; Sreevatsava M; Burton A; Malankar P; Chatterjee A; Sutter RW Vaccine; 2011 Aug; 29(34):5793-801. PubMed ID: 21641951 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [TBL] [Abstract][Full Text] [Related]
54. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine]. Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580 [TBL] [Abstract][Full Text] [Related]
55. Oral poliovaccine: will it help eradicate polio or cause the next epidemic? Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227 [TBL] [Abstract][Full Text] [Related]
57. [Oral polio vaccine in infants does not interfere in detection of enterovirus in blood]. González M; Sandoval C; Valenzuela P; Montecinos L; Martínez C; Godoy P; Abarca K Rev Chilena Infectol; 2013 Dec; 30(6):626-9. PubMed ID: 24522306 [TBL] [Abstract][Full Text] [Related]
58. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191 [TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines. Lu CY; Kao CL; Lee CY; Lee PI; Huang LM J Formos Med Assoc; 2001 Aug; 100(8):513-8. PubMed ID: 11678000 [TBL] [Abstract][Full Text] [Related]
60. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]